Last ¥3,190 JPY
Change Today +40.00 / 1.27%
Volume 25.8K
4694 On Other Exchanges
As of 1:00 AM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

bml inc (4694) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/1/14 - ¥4,175
52 Week Low
10/17/14 - ¥2,721
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BML INC (4694)

Related News

No related news articles were found.

bml inc (4694) Related Businessweek News

No Related Businessweek News Found

bml inc (4694) Details

BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and preventive medicine services. It also develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, as well as subsequent test procedures; and provides electronic medical charts and network information services. In addition, the company offers services in food sanitation control and food processing environments comprising contract services for microorganism testing of raw materials, and prepared processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and waste water tests; work sanitation management support services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal disease; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. It also arranges and coordinates clinical research for pharmaceutical manufactures; operates as a quality assurance unit for assurance of clinical research results; and develops Omness, a clinical trial support system. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan.

3,912 Employees
Last Reported Date: 06/27/14
Founded in 1955

bml inc (4694) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bml inc (4694) Key Developments

BML Inc. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2014; Announces Dividend for the Second Quarter Ended September 30, 2014, Payable on December 4, 2014; Provides Dividend Guidance for the Fourth Quarter Ending March 31, 2015; Provides Earnings Guidance for the Full Year Ending March 31, 2015

BML Inc. announced consolidated earnings results for the six months ended September 30, 2014. For the six months, the company reported net sales of ¥52,960 million against ¥50,055 million a year ago. Operating income was ¥4,180 million against ¥4,869 million a year ago. Ordinary income was ¥4,368 million against ¥5,103 million a year ago. Net income was ¥2,431 million against ¥2,937 million a year ago. Diluted net income per share was ¥114.13 against ¥137.92 a year ago. Income before income taxes and minority interests was ¥4,036 million against ¥5,086 million a year ago. Net cash provided by operating activities was ¥6,137 million against ¥6,102 million a year ago. Purchase of property, plant and equipment was ¥1,599 million against ¥983 million a year ago. Purchase of intangible assets was ¥416 million against ¥508 million a year ago. The company announced a dividend of ¥25.00 per share for the second quarter ended September 30, 2014. The scheduled date for payment of dividends will be on December 4, 2014. For the fourth quarter ending March 31, 2015, the company expects to pay a dividend of ¥35.00 per share. The company provided earnings guidance for the full year ending March 31, 2015. For the year, the company expects to report net sales of ¥104,350 million, operating income of ¥6,650 million, ordinary income of ¥7,050 million, and net income of ¥3,810 million or ¥179.39 per share.

BML Inc., Q2 2015 Earnings Call, Nov 13, 2014

BML Inc., Q2 2015 Earnings Call, Nov 13, 2014

BML Inc. to Report Q2, 2015 Results on Nov 11, 2014

BML Inc. announced that they will report Q2, 2015 results on Nov 11, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4694:JP ¥3,190.00 JPY +40.00

4694 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4694.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4694 Industry Range
Price/Earnings 13.9x
Price/Sales 0.6x
Price/Book 1.1x
Price/Cash Flow 14.4x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BML INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at